M. Alexander Otto, MMS, PA Screening of healthy men with the prostate-specific antigen (PSA) blood test has increased in recent years in the United States. This is despite the fact that the US Preventive Services Task Force has recommended against routine screening of healthy men since 2012. There was a bit of a change in...
Tag: <span>PSA</span>
Post
PSA screening: Benefit does not outweigh harm
Some men benefit from an earlier cancer diagnosis; however, more men are at risk of overdiagnosis and treatment-related complications; studies have yet to show whether a risk-adapted approach will affect this conclusion The benefit of population-based PSA screening for men with an average risk of prostate cancer does not outweigh the harm caused. This is...
Post
PSA levels no different with exposure to antidiabetes meds
(HealthDay)—Men exposed to antidiabetic medications do not have different prostate-specific antigen (PSA) levels, and prostate cancer detection rates at biopsy do not differ regardless of trigger PSA levels, according to a study published online Nov. 6 in JAMA Network Open. Kerri Beckmann, Ph.D., from King’s College London, and colleagues examined the correlations of antidiabetic medication...
Post
PSA screening reduces prostate cancer deaths by 30%
PSA-screening cuts deaths from prostate cancer by some 30%. This is shown by research based on data on 20,000 men monitored for more than two decades. The men’s initially measured PSA level proved highly significant as a predictor of future cancer risk. “This research is important because it shows the long-term effects of an organized...